3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 95.0%, 5g

N,N-Diethyl-4-methylaniline, 95.0%, 25ml

TERT-BUTYL 4,6,7,8-TETRAHYDROPYRAZOLO[4,3-C]AZEPINE-5(2H)-CARBOXYLATE, 95.0%, 100mg

4-Methylnicotinamide, 95.0%, 250mg

3-AMINOTHIETANE 1,1-DIOXIDE HCL, 95.0%, 1g

N-(3-Bromo-4-chlorophenyl)acetamide, 95%, 100mg

Cyclopropyl 3-fluoro-4-methoxyphenyl ketone, 97.0%, 1g

Phase contrast slide set with 10x and S40x PLPHi IOS infinity corrected objectives and phase contrast rings for 10x/S40x

2-(2-(BENZYLOXY)PHENOXY)-5-PHENYLPENTANOIC ACID, 95.0%, 1g

2-Amino-4-(trifluoromethyl)benzamide, 95.0%, 250mg

4'-Carboethoxy-2,2,2-trifluoroacetophenone, 97.0%, 1g

Methyl 6-bromo-4-methylnicotinate, 97%, 1g

1-(3-Chlorophenyl)-3-(piperidin-4-yl)urea hydrochloride, 95.0%, 1g